Shanghai Biolang Bio-tech Co., Ltd.

Company Introduction

Biolang Bio-tech was founded in 2004, with the headquarter and the foreign trade department in Shanghai, the subordinate R&D center in Optics Valley Biolake, the logistics center in Wuhan Guanggu Biological Medicne Garden, the production bases in Luotian, Tongshan, Dongying, Pingxiang and other cities. Biolang is engaged with the research and development of new-type drugs, the screening of crystalline compounds, the custom synthesis service of pharmaceutical intermediates and pharmaceutical raw materials, the import and export business, the procurement outsourcing and sales agents service of pharmaceutical chemicals.
In order to better serve our customers, Biolang has assembled a R&D team that lead by 5 doctors, which allows the process development , the pilot-scale process and large scale production of multiple projects at the same time. Meanwhile, the company has built a cGMP production base, more than 5,000 square meters, the company has passed the investigation by FDA, the company has the ability for the mass production(g-kg-t) of pharmaceutical intermediates. More than that, the company has set up a 1000 square meters logistics center in Wuhan of the thoroughfare of nine Provinces, which has raw materials available in stock valued more than $1.5 million, the center can send out 10 thousands parcels within a single day.
Biolang has cooperated with many well-known colleges and universities and research institutions on new-type drugs R&D, among which are Wuhan University, Shanghai University, China Medical University, China Pharmaceutical University, Shenyang Pharmaceutical University, Shanghai Institutes for Biological Sciences, Chinese Institute of Biotechnology and others. Meanwhile, the company has extensive cooperation with pharmaceutical company like Shijiazhuang Pharmaceutical Group, Huayao Group, Langbo Pharmaceutical and other big pharmaceutical companies to expand the export business. All the time, colleagues take Biolang as a trustworthy partner of long-term business, and we also hope to establish a friendship with more and more colleagues in this industry, we stick to the aim of "mutual benefit and common development", together we will go towards a better tomorrow.

View All »
ContactsPenny Smith